Addex therapeutics to release half-year 2023 financial results and host conference call on august 10, 2023

Geneva, switzerland, august 3 , 2023 – addex therapeutics (six and nasdaq: adxn), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that it will issue its half-year 2023 financial results on august 10, 2023. tim dyer, ceo, robert lÜtjens, head of discovery – biology and mikhail kalinichev, head of translational science, will provide a business update and a review of the addex product pipeline during a teleconference and webcast for investors, analysts and media at 16:00 cest (15:00 bst / 10:00 edt / 07:00 pdt) the same day.
ADXN Ratings Summary
ADXN Quant Ranking